{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:37:41Z","timestamp":1794724661737,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ygyno.2025.10.030","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:31:39Z","timestamp":1764005499000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Radiation therapy for the gynecologic oncologist"],"prefix":"10.1016","volume":"204","author":[{"given":"Han T.","family":"Cun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina M.","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2025.10.030_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brachy.2007.08.009","article-title":"Classics in brachytherapy: Margaret cleaves introduces gynecologic brachytherapy","volume":"6","author":"Aronowitz","year":"2007","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cam4.187","article-title":"Uterine cervix cancer treatment at Radiumhemmet: 90 years\u2019 experience. Time trends of age, stage, and histopathology distribution","volume":"3","author":"Hellman","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.ygyno.2025.10.030_bb0015","author":"Radiation Biology"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1148\/radiol.2016160200","article-title":"Utility of PET\/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial Cancer: results of ACRIN 6671\/GOG 0233 trial","volume":"283","author":"Atri","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2020.11.032","article-title":"A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer","volume":"160","author":"Pareek","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2018.06.014","article-title":"Tumor shrinkage during chemoradiation in locally advanced cervical Cancer patients: prognostic significance, and impact for image-guided adaptive brachytherapy","volume":"102","author":"Schernberg","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.10.030_bb0040","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.030_bb0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cncr.27652","article-title":"The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy","volume":"119","author":"Song","year":"2013","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.ygyno.2025.10.030_bb0055","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.ygyno.2025.10.030_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133526","article-title":"Stereotactic body radiation therapy in Gynecologic Oligometastases: an effective but underutilized approach","volume":"15","author":"Sherwani","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ygyno.2025.10.030_bb0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamaoncol.2024.1796","article-title":"Stereotactic ablative radiotherapy for gynecological oligometastatic and oligoprogessive tumors","volume":"10","author":"Donovan","year":"2024","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.10.030_bb0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ygyno.2021.12.022","article-title":"Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: a landmark analysis","volume":"164","author":"Corrigan","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.030_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00066-024-02319-2","article-title":"Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies","volume":"201","author":"Meixner","year":"2025","journal-title":"Strahlenther. Onkol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpainsymman.2020.08.011","article-title":"A retrospective study of rapid symptom response in bleeding Gynecologic malignancies with short course palliative radiation therapy: less is more","volume":"61","author":"Butala","year":"2021","journal-title":"J. Pain Symptom Manage."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.030_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3857\/roj.2013.31.4.216","article-title":"Short-course palliative radiotherapy for uterine cervical cancer","volume":"31","author":"Kim","year":"2013","journal-title":"Radiat. Oncol. J."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0095","article-title":"Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials","volume":"2002","author":"Sze","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.030_bb0100","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0360-3016(01)01733-3","article-title":"Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma","volume":"51","author":"Tinger","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.030_bb0105","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.10.030_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2019.01.012","article-title":"Importance of training in external beam treatment planning for locally advanced cervix cancer: report from the EMBRACE II dummy run","volume":"133","author":"Seppenwoolde","year":"2019","journal-title":"Radiother. Oncol."},{"issue":"33","key":"10.1016\/j.ygyno.2025.10.030_bb0115","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical Cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2025.10.030_bb0120","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.030_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jmrs.311","article-title":"The role of volumetric modulated arc therapy (VMAT) in gynaecological radiation therapy: a dosimetric comparison of intensity modulated radiation therapy versus VMAT","volume":"66","author":"Knapp","year":"2019","journal-title":"J. Med. Radiat. Sci."},{"issue":"6","key":"10.1016\/j.ygyno.2025.10.030_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0362","article-title":"Quality-of-life outcomes and toxic effects among patients with cancers of the uterus treated with stereotactic pelvic adjuvant radiation therapy: the SPARTACUS phase 1\/2 nonrandomized controlled trial","volume":"8","author":"Leung","year":"2022","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.10.030_bb0135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ygyno.2021.04.010","article-title":"Stereotactic body radiotherapy for the treatment of gynecologic malignancies: passing fancy or here to stay?","volume":"161","author":"Hutten","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.030_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijrobp.2015.07.2205","article-title":"Initial report of pencil beam scanning proton therapy for Posthysterectomy patients with Gynecologic Cancer","volume":"95","author":"Lin","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ygyno.2025.10.030_bb0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ijgc-2021-002459","article-title":"The role of proton therapy in gynecological radiation oncology","volume":"32","author":"Taunk","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4 Suppl","key":"10.1016\/j.ygyno.2025.10.030_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/15330346070060S403","article-title":"Dosimetry aspects of proton therapy","volume":"6","author":"Patyal","year":"2007","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2025.10.030_bb0155","doi-asserted-by":"crossref","unstructured":"A.L. Russo, et al., Long-term results of a phase 2 study of adjuvant proton radiation therapy for node-positive Cancer of the uterus and cervix, Int. J. Radiat. Oncol. Biol. Phys. 2025 Aug 1;122(5)1301-1309.","DOI":"10.1016\/j.ijrobp.2025.03.010"},{"key":"10.1016\/j.ygyno.2025.10.030_bb0160","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Potter","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.030_bb0165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2025.10.030_bb0170","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical Cancer: results from the EMBRACE-I study","volume":"41","author":"Schmid","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.030_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020362","article-title":"Hypofractionated radiotherapy in Gynecologic malignancies-a peek into the upcoming evidence","volume":"16","author":"Amjad","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"16_suppl","key":"10.1016\/j.ygyno.2025.10.030_bb0180","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS5631","article-title":"RT-PACE: phase I\/II study of adjuvant whole pelvic hypofractionated radiotherapy for non-metastatic cervical and endometrial cancer","volume":"41","author":"Son","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.030_bb0185","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.009","article-title":"Radiobiological analysis of outcomes using external beam radiotherapy plus high dose-rate brachytherapy (4x7 Gy or 2x9 Gy) for cervical Cancer in a multi-institution trial","volume":"99","author":"Hendry","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2025.10.030_bb0190","article-title":"Short-course adjuvant vaginal cuff brachytherapy in early endometrial Cancer compared with standard of care (SAVE): a randomized clinical trial","volume":"1","author":"Suneja","year":"2024","journal-title":"JCO Oncol. Adv."},{"issue":"27","key":"10.1016\/j.ygyno.2025.10.030_bb0195","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial Cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2025.10.030_bb0200","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2025.10.030_bb0205","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial Cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.10.030_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2025.01.006","article-title":"Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: ancillary analysis of GOG-0258","volume":"193","author":"Clements","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2025.10.030_bb0215","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial Cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ygyno.2025.10.030_bb0220","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ygyno.2025.10.030_bb0225","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.annonc.2024.08.2242","article-title":"ENGOT-en11\/GOG-3053\/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer","volume":"35","author":"Van Gorp","year":"2024","journal-title":"Ann. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:31:44Z","timestamp":1764005504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825010546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S0090825825010546"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.030","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy for the gynecologic oncologist","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}